Gabapentin as add-on to morphine for severe neuropathic or mixed pain in children from age 3 months to 18 years - evaluation of the safety, pharmacokinetics, and efficacy of a new gabapentin liquid formulation: study protocol for a randomized controlled trial

BACKGROUND: Gabapentin has shown efficacy in the treatment of chronic neuropathic or mixed pain in adults. Although pediatric pain specialists have extensive experience with gabapentin for the treatment of neuropathic pain, its use is off-label. Its efficacy and safety in this context have never bee...

Descripción completa

Detalles Bibliográficos
Autores principales: de Leeuw, Thomas G., Mangiarini, Laura, Lundin, Rebecca, Kaguelidou, Florentia, van der Zanden, Tjitske, Pasqua, Oscar Della, Tibboel, Dick, Ceci, Adriana, de Wildt, Saskia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334401/
https://www.ncbi.nlm.nih.gov/pubmed/30646965
http://dx.doi.org/10.1186/s13063-018-3169-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334401/
https://www.ncbi.nlm.nih.gov/pubmed/30646965
http://dx.doi.org/10.1186/s13063-018-3169-3

Ejemplares similares